Pharma and Biotech
| Competitors: | Hemogenyx Pharmaceuticals |
| Executive Director: | Daniel Gooding |
| Independent Non-Executive Director: | Madeleine (“Maddy”) Kennedy |
| Non-Executive Chairman: | Tim Metcalfe |
| Non-Executive Dir: |
| Address: | C/O Arch Law Limited, Huckletree Bishopsgate, 8 Bishopsgate, London, United Kingdom, EC2N 4BQ |
| Phone: | +44 (0)1223 627222 |
| Website: | https://nuformix.com/ |
| Sector: | Pharma and Biotech(LSE) |
| ISIN: | GB00BYW79Y38 |
| Currency | UK Pounds |
| Share Price | 0.095p |
| Change Today | 0.000p |
| % Change | 0.00 % |
| 52 Week High | 0.34 |
| 52 Week Low | 0.092 |
| Volume | 16,634,666 |
| Shares Issued | 2,609.75m |
| Market Cap | £2.48m |
| RiskGrade | 322 |
| Value |
|
|---|
| Price Trend |
|
|---|
| Income | ![]() |
|---|
| Growth | ![]() |
|---|
| No dividends found |
| Time | Volume / Share Price |
| 15:56 | 1,100,000 @ 0.093p |
| 13:52 | 3,250,000 @ 0.092p |
| 13:12 | 7,380,683 @ 0.093p |
| 09:59 | 50,242 @ 0.093p |
| 09:47 | 957,519 @ 0.093p |
You are here: research